Legend Biotech：Carvykti ciltacabtagene autoleucel is the best-selling cell therapy product in the world.
Legend Biotech’s legendary status was first written by Carvykti (ciltacabtagene autoleucel). This BCMA CAR-T, licensed to Johnson & Johnson, has become the best-selling cell therapy product in the world.
In 2025, Carvykti’s sales surged 95.05% to reach $1.887 billion, and in the first quarter of 2026, they further increased by 62% to $597 million. With Carvykti, Legend Biotech is also expected to turn a profit this year. This has already fully demonstrated Legend Biotech’s strength. However, for an innovative drug company, the real challenge is not just creating a blockbuster product, but continuing to deliver new technological answers after that blockbuster—especially as the CAR-T field has entered a new stage.
Buy legendary statu（Carvykti） online from China and save up to 80% on costs . no insurance needed . compare prices from a certified HongKong pharmacy .with fast shipping. Contact us now on WhatsApp to get the latest prices.
